Etudes cliniques et résultats Sanofi pharma, incluant Sanofi Genzyme

Les informations concernant les essais cliniques sponsorisés et les résultats sont fournies à titre informatif et ne sont pas destinés à promouvoir un produit ou une utilisation. Les résultats des essais cliniques ont pour objectif de partager les résultats connus au moment de la réalisation de l'étude correspondante. Les résultats ne fournissent pas un examen complet et actuel de la sécurité ni de l'efficacité d'un médicament en particulier sur la base des informations disponibles. Les médecins et les patients doivent se référer à l'autorisation de mise sur le marché approuvée dans leur pays pour connaitre les indications en vigueur localement.
Ces informations n'ont pas pour intention de remplacer les conseils d'un professionnel de santé. Seul un médecin peut déterminer si un médicament spécifique convient ou s'apparente au meilleur traitement pour un patient en particulier. Si vous avez des questions, veuillez consulter un professionnel de santé.

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Etudes cliniques et résultats Sanofi pharma, incluant Sanofi Genzyme – Lettre A

Nom générique Nom commercial Condition Code étude Nom de l'étude Accéder aux études Accéder aux résultats
AFLIBERCEPT Zaltrap Cancer TES10897 QUTIE EudraCT: 2008-006796-80
AFLIBERCEPT Zaltrap Cancer ARD6122 NA NCT00327171
AFLIBERCEPT Zaltrap Cancer ARD6123 NA NCT00284141
AFLIBERCEPT Zaltrap Cancer EFC6125 NA NCT00327444
AFLIBERCEPT Zaltrap Cancer EFC6546 NA NCT00519285
AFLIBERCEPT Zaltrap Cancer ARD6772 NA NCT00396591
AFLIBERCEPT Zaltrap Cancer EFC10262 VELOUR NCT00561470
AFLIBERCEPT Zaltrap Cancer EFC10261 VITAL NCT00532155
AFLIBERCEPT Zaltrap Cancer EFC10547 VANILLA NCT00574275
AFLIBERCEPT Zaltrap Cancer EFC10668 AFFIRM NCT00851084
AFLIBERCEPT Zaltrap Cancer EFC10668 AFFIRM NCT00851084
AFLIBERCEPT Zaltrap Cancer TCD11382 NA NCT01148615
AFLIBERCEPT Zaltrap Cancer TCD11470 NA NCT01930552
AFLIBERCEPT Zaltrap Colorectal cancer AFLIBC06561 AMOR NCT01955629
AFLIBERCEPT Zaltrap Cancer TCD6117 NA NA
AFLIBERCEPT Zaltrap Colorectal cancer EFC11338 AFLAME NCT01661270
AFLIBERCEPT Zaltrap Colorectal cancer EFC11885 NA NCT01882868
AFLIBERCEPT Zaltrap Non Hodgkins Lymphoma TCD10173 NA NCT00644124
AFLIBERCEPT Zaltrap Colorectal cancer AFLIBL06266 AFEQT NCT01670721
AFLIBERCEPT Zaltrap Colorectal cancer AFLIBC06097 NA EudraCT: 2011-005724-17
AGALSIDASE BETA Fabrazyme Fabry Disease AGAL-005-99 NA NCT00074971
AGALSIDASE BETA Fabrazyme Fabry Disease AGAL-006-99* NA
AGALSIDASE BETA Fabrazyme Fabry Disease AGAL-007-99* NA
AGALSIDASE BETA Fabrazyme Fabry Disease AGAL-008-00 NA NCT00074984
AGALSIDASE BETA Fabrazyme Fabry Disease AGAL-016-01 NA NCT00074958
AGALSIDASE BETA Fabrazyme Fabry Disease AGAL-017-01 NA NCT00196716
AGALSIDASE BETA Fabrazyme Fabry Disease AGAL-019-01* NA
AGALSIDASE BETA Fabrazyme Fabry Disease AGAL-022-02 NA NCT00837824
AGALSIDASE BETA Fabrazyme Fabry Disease AGAL02503 NA NCT00081497
AGALSIDASE BETA Fabrazyme Fabry Disease AGAL06207 FIELD NCT00701415
AGALSIDASE BETA Fabrazyme Fabry Disease AGAL03204 NA NCT00140621
AGALSIDASE BETA Fabrazyme Fabry Disease AGAL-1-002-98* NA
AGALSIDASE BETA Fabrazyme Fabry Disease AGAL19110 NA EudraCT: 2012-001966-14
AGALSIDASE BETA Fabrazyme Fabry Disease AGAL19412 NA NCT01650779
AGALSIDASE BETA Fabrazyme Fabry Disease FB9702-01* NA
ALEMTUZUMAB Campath Leukemia CAM203 NA NCT00328198
ALEMTUZUMAB Campath Leukemia CAM211* NA
ALEMTUZUMAB Campath Leukemia CAM307* NA NCT00046683
ALEMTUZUMAB Campath Leukemia CAM314 NA NCT00086580
ALEMTUZUMAB Lemtrada Multiple Sclerosis CAMMS223 NA NCT00050778
ALEMTUZUMAB Lemtrada Multiple Sclerosis CAMMS323 CARE-MS I NCT00530348
ALEMTUZUMAB Lemtrada Multiple Sclerosis CAMMS32400507 CARE-MS II NCT00548405
ALEMTUZUMAB Lemtrada Multiple Sclerosis CAMMS03409 CARE-MS II NCT00548405
ALEMTUZUMAB Lemtrada Multiple Sclerosis LPS13650 EMERALD EudraCT: 2014-000092-62
ALFUZOSIN Uroxatral, Xatral Prostatic Diseases ALFUS_L_01241 SAMBA_THAILAND NCT00401661
ALFUZOSIN Uroxatral, Xatral Prostatic Diseases ALFUS_L_01667 SAMBA NCT00486785
ALFUZOSIN Uroxatral, Xatral Benign Prostatic Hyperplasia DRI5234 NA NCT00409357
ALFUZOSIN Uroxatral, Xatral Benign Prostatic Hyperplasia EFC4428 ALFAURUS NCT00290030
ALFUZOSIN Uroxatral, Xatral Benign Prostatic Hyperplasia EFC4485 NA NCT00029822
ALFUZOSIN Uroxatral, Xatral Neurogenic Urinary Bladder EFC5722 ALPHACHIN NCT00549939
ALFUZOSIN Uroxatral, Xatral Benign Prostatic Hyperplasia EFC5791 NA NCT00399464
ALFUZOSIN Uroxatral, Xatral Hydronephosis Neurogenic Bladder EFC6269 ALPHAHYDRO NCT00576823
ALFUZOSIN Uroxatral, Xatral Prostatic Diseases L_8472 ALF-ACUTE NCT00540891
ALFUZOSIN Uroxatral, Xatral Prostatic Diseases L_8758 NA NCT00637715
ALFUZOSIN Uroxatral, Xatral Prostatic Diseases L_8819 NA NCT00542165
ALFUZOSIN Uroxatral, Xatral Prostatic Diseases L_8935 ALEX-XL NCT00575913
ALFUZOSIN Uroxatral, Xatral Urologic Diseases L_9397 ALF-RIK NCT00453908
ALFUZOSIN Uroxatral, Xatral Prostatic Diseases L_9645 NA NCT00336921
ALFUZOSIN Uroxatral, Xatral Calculi L_9795 ALF-STONE EudraCT: 2005-005481-36
ALFUZOSIN Uroxatral, Xatral Benign Prostatic Hyperplasia LTS5235 NA NCT00347061
ALFUZOSIN Uroxatral, Xatral Urinary Bladder Neurogenic PKM6270 ALPHACHIP NCT00629720
ALFUZOSIN Uroxatral, Xatral Prostatic Diseases PM_L_0168 ALFONE CHINA NCT00280605
ALGLUCOSIDASE ALFA Myozyme Pompe Disease AGLU01602 NA NCT00059280
ALGLUCOSIDASE ALFA Myozyme Pompe Disease AGLU01702 NA EudraCT: 2004-002168-59
ALGLUCOSIDASE ALFA Myozyme Pompe Disease AGLU02704 NA NCT00158600
ALGLUCOSIDASE ALFA Myozyme Pompe Disease AGLU02804 NA EudraCT: 2005-002829-31
ALGLUCOSIDASE ALFA Myozyme Pompe Disease AGLU03206 NA NCT00455195
ALGLUCOSIDASE ALFA Myozyme Pompe Disease AGLU03306 NA NCT00483379
ALGLUCOSIDASE ALFA Myozyme Pompe Disease AGLU03807 NA NCT00701129
ALGLUCOSIDASE ALFA Myozyme Pompe Disease AGLU07310 NA NCT01288027
ALGLUCOSIDASE ALFA Myozyme Pompe Disease AGLU07510 NA NCT01597596
ALGLUCOSIDASE ALFA Myozyme Pompe Disease AGLU09411 NA NCT01526785
ALIROCUMAB Praluent Hypercholesterolemia DFI11565 NA NCT01288443
ALIROCUMAB Praluent Hypercholesterolemia DFI11566 NA NCT01288469
ALIROCUMAB Praluent Hypercholesterolemia DFI12361 NA NCT01812707
ALIROCUMAB Praluent Hypercholesterolemia EFC14074 NA NCT02289963
ALIROCUMAB Praluent Hypercholesterolemia EFC11568 ODYSSEY COMBO I NCT01644175
ALIROCUMAB Praluent Hypercholesterolemia EFC11569 ODYSSEY COMBO II NCT01644188
ALIROCUMAB Praluent Hypercholesterolemia EFC11716 ODYSSEY MONO NCT01644474
ALIROCUMAB Praluent Hypercholesterolemia EFC12492 ODYSSEY FH I NCT01623115
ALIROCUMAB Praluent Hypercholesterolemia EFC12732 ODYSSEY HIGH FH NCT01617655
ALIROCUMAB Praluent Hypercholesterolemia EFC13672 ODYSSEY JAPAN NCT02107898
ALIROCUMAB Praluent Hypercholesterolemia EFC13786 ODYSSEY CHOICE II NCT02023879
ALIROCUMAB Praluent Hypercholesterolemia EFC14305 ODYSSEY-NIPPON NCT02584504
ALIROCUMAB Praluent Dyslipidemia LPS14354 ODYSSEY DM-Dyslipidemia NCT02642159
ALIROCUMAB Praluent Hypercholesterolemia LPS14355 ODYSSEY DM-Insulin NCT02585778
ALIROCUMAB Praluent Hypercholesterolemia LTS11717 ODYSSEY LONG TERM NCT01507831
ALIROCUMAB Praluent Hypercholesterolemia POP12671 NA NCT01670734
AMIBEGRON Not marketed Major Depressive Disorder EFC4846 ZEPHIR NCT00319709
AMIBEGRON Not marketed Major Depressive Disorder EFC5041 ORION NCT00252356
AMIBEGRON Not marketed Major Depressive Disorder EFC5116 PHOENIX NCT00252330
AMIBEGRON Not marketed Major Depressive Disorder EFC5374 NA NCT00825058
AMIBEGRON Not marketed Major Depressive Disorder EFC5379 NA NCT00825019
AMIBEGRON Not marketed Generalized anxiety disorder EFC5891 ELECTRA EudraCT: 2005-003180-23
AMIBEGRON Not marketed Generalized anxiety disorder EFC5892 LIBRA NCT00252343
AMIBEGRON Not marketed Generalized anxiety disorder EFC5893 AQUARIUS EudraCT: 2005-003181-41
AMIBEGRON Not marketed Generalized anxiety disorder EFC5895 GEMINI EudraCT: 2006-004147-33
AMIBEGRON Not marketed Major Depressive Disorder EFC6224 ALBERIO EudraCT: 2006-004146-16
AMIBEGRON Not marketed Major Depressive Disorder EFC6607 SIRIUS NCT00385307
AMIBEGRON Not marketed Major Depressive Disorder LTE5376 CALYPSO EudraCT: 2005-004006-81
AMIBEGRON Not marketed Generalized anxiety disorder LTE5894 VEGA EudraCT: 2006-002253-71
AMIBEGRON Not marketed Major Depressive Disorder LTS4848 NA EudraCT: 2005-000577-21
AMISULPRIDE Solian Schizophrenia AMISU_L_01008 AMIMIND EudraCT: 2007-005772-13
AMISULPRIDE Solian Bipolar Disorder C_8428 SOLMANIA NCT00126009
AMISULPRIDE Solian Schizophrenia L_8967 AMIRISMIND NA
AMISULPRIDE Solian Schizophrenia L_8968 NA NCT00331981
AMISULPRIDE Solian Schizophrenia L_9517 ASAP NCT00436371
AMISULPRIDE Solian Schizophrenia PM_L_0055 SOLIACS EudraCT: 2004-004461-15
AMISULPRIDE Solian Schizophrenia AMISUL06155 ESCAPE NCT01795183
ANTI-PNAG MONOCLONAL ANTIBODY Not marketed Infection prophylaxis PKD11791 NA NCT01389700
ANTI-THYMOCYTE GLOBULIN (RABBIT) Thymoglobulin kidney transplant rejection SANG-93-3-K-THY-R* NA
ANTI-THYMOCYTE GLOBULIN (RABBIT) Thymoglobulin kidney transplant rejection SANG-96-3-K-THY-I* NA
ANTI-THYMOCYTE GLOBULIN (RABBIT) Thymoglobulin kidney transplant rejection SMC-101-1002* NA
ANTI-THYMOCYTE GLOBULIN (RABBIT) Thymoglobulin kidney transplant rejection SMC-101-1007* NA
ANTI-THYMOCYTE GLOBULIN (RABBIT) Thymoglobulin kidney transplant rejection SMC-101-1008* NA
ANTI-THYMOCYTE GLOBULIN (RABBIT) Thymoglobulin kidney transplant rejection SMC-101-1009* NA
ANTI-THYMOCYTE GLOBULIN (RABBIT) Thymoglobulin kidney transplant rejection SMC-534-1003* NA
ARTESUNATE Arsucam Malaria ARTEN_L_00848 ACT MALI NCT00452907
ARTESUNATE Arsucam Malaria PM_L_0163 ATOL NCT00445796
ARTESUNATE + AMODIAQUINE Coarsucam Malaria ARAMF_L_01570 NA NCT00386503
ARTESUNATE + AMODIAQUINE Coarsucam Malaria ARAMF_L_02873 NA NCT00540410
ARTESUNATE + AMODIAQUINE Coarsucam Malaria PM_L_0164 ATAQ EASY NCT00316329
ARTESUNATE + AMODIAQUINE Coarsucam Malaria ARAMF_L_02661 NA NCT00699920
ARTESUNATE + AMODIAQUINE Coarsucam Malaria ARAMF_C_05370 NA NCT01378286
ARTESUNATE + AMODIAQUINE Coarsucam Malaria ARAMF_L_04314 NA NCT01023399
ATACIGUAT Not marketed Pain, Neuropathic DFI10569 SERENEATI EudraCT: 2008-001518-26
ATACIGUAT Not marketed Peripheral Arterial Disease DFI6174 ACCELA NCT00443287
AVANAFIL Spedra Erectile Dysfuntion AVANAL07163 CEDAR NCT02503306

Références :
*Ces résultats d'étude ont précédemment été publiés sur GenzymeClinicalResearch.com
**Ce lien remplace le même rapport précédemment publié